Added value of sGC stimulator in worsening HFrEF patients - PACE-CME

Added value of sGC stimulator in worsening HFrEF patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Use of ARNI in HFpEF patients reduces NT-proBNP levels
Use of ARNI in HFpEF patients reduces NT-proBNP levels
ACC 2020
Use of ARNI in HFpEF patients reduces NT-proBNP levels
- Jonathan Cunningham, MD
Mechanistic underpinning of CV benefit observed with icosapent ethyl
Mechanistic underpinning of CV benefit observed with icosapent ethyl
ACC 2020
Mechanistic underpinning of CV benefit observed with icosapent ethyl
- Deepak Bhatt, MD
Higher rate of smoking cessation with e-cigarettes compared to counseling
Higher rate of smoking cessation with e-cigarettes compared to counseling
ACC 2020
Higher rate of smoking cessation with e-cigarettes compared to counseling
- Prof. Mark Eisenberg, MD
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
ACC 2020
Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH
- Prof. Frederick Raal